Test Android StudyStack App
Please help StudyStack get a grant! Vote here.
or...
Reset Password Free Sign Up

Free flashcards for serious fun studying. Create your own or use sets shared by other students and teachers.


incorrect cards (0)
correct cards (0)
remaining cards (0)
Save
0:01
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the Correct box, the DOWN ARROW key to move the card to the Incorrect box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

Correct box contains:
Time elapsed:
Retries:
restart all cards



Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

Beh Med Ph Depressn

Behav Med Pharm I

QuestionAnswer
SSRI MOA Selectively inhibit 5-HT reuptake by blocking 5-HT transporter
SSRI: Most potent SSRIs re: blocking 5-HT transporter paroxetine & citalopram
SSRIs that produce effect on NE: Fluoxetine and paroxetine (doses > 40mg)
SSRIs: Advantages Low affinity for histamine- 1, alpha-1, muscarinic (M) rec; so low sedation, no orthostasis, dry mouth or CV issues
SSRI w/longest half life fluoxetine
Most common AE reason for SSRI early DC GI problems (titrate slowly, take w/meals)
most common SSRI AE when starting drug Akathisia (esp w/fluoxetine)
Tx for SSRI akathisia Start low, early AM, benzo, trazo, propanolol
Sexual dysfn greatest/least with: greatest: paroxetine; least: citalopram
SSRI AE: sedation greatest with: paroxetine (d/t anticholinergic properties)
Serotonin syndrome S/S Hyperreflexia, tremor, GI complaints, CV problems, seizures, respiratory depression, coma, death; concern re: SSRI combo w/other drugs
SSRI withdrawal S/S Nightmares, flu-like symptoms, GI, shock-like sensations, & insomnia (seen usually in 2 to 7 days after abrupt d/c)
SSRI withdrawal worst with: paroxetine & sertraline (switch to fluox?)
SSRI benefit seen in: atypical, psychotic, and dysthymia
Fluoxetine effective dose range 20-40 mg/day
Wt gain: SSRIs with greatest/least Least: fluox; greatest: paroxetine
Paroxetine effective dose range 30-50 mg/day
Citalopram/escitalopram effective dose range 20-60 mg/day
Lexapro effective dose range 10-20mg/day
Classes: equal in depression tx SSRI, SNRI, atypicals
SNRI MOA Block reuptake of 5-HT and NE (& DA)
SNRI MOA: Venlafaxine only produces effects on NE at: a higher dose (so push dose pretty high)
SNRI MOA: Duloxetine has a high level of effect on: both 5-HT and NE
SNRI good to tx: refractory depression, melancholy; more physical pain sx of depn; comorbid pain (duloxetine: DM periph neuropathy)
SNRI AE profile (which worse?) Venlafaxine > duloxetine
SNRI side fx GI (1st 3 wks); HTN (dose-dept (DBP) venlafaxine); withdrawal sim to SSRI
Use venlafaxine IR cautiously in pts with: HTN & cardiac dysfunction (use dulox or venla XR)
Mirtazapine (atypical) MOA unique: blocks central alpha-2 recs increasing NE & 5-HT; antag 5-HT2, 5-HT3 post-synaptic recs
Mirtazapine AE Somnolence, wt gain/inc appetite (used in cachectic pts), ortho hypotn
Bupropion MOA Weak reuptake inhibitor of NE and DA
Bupropion active metabolite: hydroxybupropion; has amphetamine properties (potent reuptake inhibitor of both NE and DA)
Bupropion AE Lower seizure threshold; vivid nightmares, delusions, psychosis
Do not give Bupropion to pts with: eating disorders (low electrolytes): seizure risk
Bupropion dosing Highest dose s/b usu 300; dose at early AM and noon (d/t insomnia, etc)
Atypical: good option for pts with sedation / fatigue / sexual dysfunction Bupropion
TCA MOA Block the reuptake of 5-HT and N; 1stGen: greater effect on 5-HT reuptake (Doxepin); 2ndGen: greater effect on NE reuptake (esp desipramine; clomipramine)
TCAs with best blockade of alpha- 1 & histamine- 1 recs: Amitriptyline & doxepin
TCA AE Anticholinergic (dry mouth, urin hesitancy, GERD; Cardiovascular (ortho hypotn, tachy, conduction, HTN); CNS (tremor, sedation, myoclonic twitch); wt gain; sexual dysfn
TCA dosing Start at low dose, titrate slowly, switch to less offensive agent; Bethanechol for anticholinergic AE; lethal in OD
MAOI MOA Block destruction of monoamines by presynaptic neuronal MAO; effect both central & periph; MAO-A = on NE & 5-HT; MAO-B = on phenylethylamine & DA
Irreversible MAO-I = Phenelzine & tranylcypromine
MAOI AE Wt gain; rash (selegiline); diet restrictn (liver, cheese, wine, yeast)
STAR-D General findings 6 wks necessary for pts achieve response; pts unable to tolerate med preferred switch; pts able to tolerate med preferred augmentation
STAR-D: Buproprion-SR: better results than buspirone
STAR-D Level 1 start citalopram
STAR-D Level 2 switch to: buprop SR, CBT, sert, venla XR; or augment w/bupro SR, buspar, CBT
STAR-D Level 2a (if CBT in level 2): switch to: buprop SR or venla XR
STAR-D Level 3 switch to mirtaz or nortrip; or augment w/lithium (poss T3 if bupro, sert, venla)
STAR-D Level 4 switch to tranylcypromine or mirtaz combo w/venla XR
Created by: Abarnard on 2010-01-24



bad sites Copyright ©2001-2014  StudyStack LLC   All rights reserved.